ArsenalBio
PrivateLast Round
Series C
Sep 4, 2024
Total Funding Raised
$630M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ArsenalBio is a biotechnology company that discovers and develops programmable autologous T cell therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArsenalBio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ArsenalBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 4, 2024 | ||||
| Series B | Sep 6, 2022 | ||||
| Series A | Oct 17, 2019 |
Key People
Founding team and executive leadership
ArsenalBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series C, Series B |
| Westlake Village Biopartners | Series C, Series B, Series A |
| HV Fund | Series C, Series B |
| Waycross Ventures | Series B |
| ARCH Venture Partners | Series C |
| Parker Institute for Cancer Immunotherapy | Series B, Series A, Series C |
| Sixth Street Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 25, 2025
Company is testing CAR T-cell therapies in human trials.
- Jan 13, 2025
CEO to present at the J.P. Morgan Healthcare Conference on Jan 13, 2025.
ArsenalBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArsenalBio's valuation, stock price, and market status.